Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
The Boston Beer Company, through its brand Twisted Tea Hard Iced Tea, has partnered with outdoor lifestyle brand Realtree to introduce a limited-edition fall campaign featuring Realtree's iconic camouflage pattern on Twisted Tea packaging and promotional merchandise. This nationwide campaign spans product packaging, apparel, and multimedia advertis…
All In FutureTech Alliance Inc. (NASDAQ: AIFA) has launched a new corporate website to better communicate its AI-focused business strategy and global platform vision. Under new leadership, the company emphasizes building an AI-enabled platform serving global Chinese-speaking communities through education, media content, cross-border commerce, and i…
Apple's fundamentals have shifted from 'expensive-but-stable' to 'expensive-with-improving-economics.' Higher margins and robust free cash flow justify a rating upgrade. This is a long trade: enter at $341.04, stop at $320.00, target $380.00 over a long-term (180 trading days) horizon.
Forward Industries (FWDI) sells at a material discount to the implied value of its Solana treasury and operational optionality. A $25M registered direct offering at $8.00 completed on 09/24/2026 replenishes dry powder to buy SOL and increases SOL-per-share; combined with a tight float and rising technical momentum, the setup favors a tactical long …
Palisade Bio announced that its lead drug candidate, PALI-2108, designed for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease, will be featured in four presentations at UEG Week 2026. The data showcase early clinical efficacy, gut-targeted exposure, favorable safety profile, and a biomarker development to predict treatment…
Amrize (HCMLF) looks set to benefit from improving gross margins and resilient end markets. We outline a tactical long trade with clear entry, target, and stop, a 45 trading-day horizon, and a risk-aware plan. Key catalysts include margin normalization, order flow improvement, and potential positive commentary at the next trading update.
Telos Corporation has been awarded an $13.7 million contract by the U.S. Department of Health and Human Services to deploy its FedRAMP-authorized Xacta cybersecurity platform and related services over 18 months. The contract aims to modernize cyber governance, risk, and compliance processes for HHS, integrating AI-powered tools to streamline securi…
Lifecore Biomedical has agreed to be acquired by Webster Equity Partners in a transaction valued up to $663.7 million including contingent value rights based on future performance milestones. Common stockholders will receive $6.28 per share in cash at closing, representing a 49.5% premium, plus CVRs up to $160 million contingent on milestones throu…
GRI Bio, Inc., a clinical-stage biotech company developing therapies for fibrotic and autoimmune diseases, announced that its CEO and CSO will present at the upcoming 10th IPF Summit. They will share insights from Phase 2a clinical development of GRI-0621, an oral RAR β/γ-selective agonist targeting idiopathic pulmonary fibrosis (IPF). The presenta…
Riley Exploration Permian (REPX) trades like a deep-value Permian E&P with an EV/EBITDA of ~3.9x, a P/E under 8x and a $0.40 quarterly dividend. If Riley can deliver ~30% oil growth over the next year, the stock can re-rate toward mid-single-digit EV/EBITDA multiples and deliver meaningful upside. This trade outlines an entry at $40.56, a stop at $…
Sportradar (SRAD) trades at $13.25 with a $4.13B market cap. A potential strategic lift from a Meta connection could re-rate growth expectations, but class-action suits and aggressive short positioning mean I want confirmation before committing capital. Trade plan: enter at $13.25, stop $11.50, target $18.00 for a mid-term swing (45 trading days).
Cohu has already rallied hard on AI-driven test demand. Recent results and guidance show revenue growth and margin improvement that should justify further upside near-term. This is a tactical long for traders who want to ride earnings normalization into the stock while using a tight stop to limit downside if the cycle stalls.
MBody AI Ltd. announced that CEO John Fowler will present at the Lytham Partners Fall 2026 Investor Conference, showcasing the company's autonomous robot workforce platform and growth progress. The company now operates robot fleets in eleven U.S. states and Canada, servicing approximately 600 million square feet. They plan to use recent capital rai…
Idaho Copper Corporation announced that its CEO and Executive Chairman will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference. The company aims to engage institutional investors and highlight advancements in its flagship CuMo copper-molybdenum-silver project, emphasizing its status as one of the largest undeveloped copp…
Syntec Optics is showing real revenue and order momentum from space and biomedical customers, and Q2 commentary suggests an operational inflection. That said, the market has already bid the stock up aggressively — valuation metrics are rich, insider ownership and low free cash flow amplify execution risk, and short interest and short-volume activit…
Nvidia's share price has pulled back enough that its earnings and free cash flow profile look compelling versus current growth expectations. With data-center GPU demand still strong, excellent profitability and a fortress balance sheet, I'm upgrading NVDA to a Buy. Below is an actionable trade plan with entry, stop and target levels and a balanced …
Silexion Therapeutics announced promising translational research findings showing that its RNAi therapeutic candidate SIL204 leverages native serum lipids for efficient cellular uptake and potent KRAS oncogene silencing in cancer cells. This mechanism supports systemic subcutaneous administration without requiring artificial carriers, aligning with…
Achieve Life Sciences announced that it will present new data from the ORCA-OL trial demonstrating 52 weeks of cytisinicline treatment efficacy for cigarette smoking and e-cigarette cessation. The open-label study involves 475 adults and evaluates sustained abstinence, with cytisinicline showing potential as a treatment for nicotine dependence. The…
DLH Holdings Corp. has been awarded a task order valued at up to $19.1 million by the National Institutes of Health's Center for Information Technology to provide risk management framework and cybersecurity operations support. This contract spans up to three years and includes services such as security assessment, vulnerability management, incident…
Carlsmed, Inc. appoints Richard Heppenstall as Chief Financial Officer, replacing Leo Greenstein. The company is entering a pivotal growth phase with new product launches and expanded CMS reimbursement for their AI-driven personalized spine surgery solutions. Carlsmed reaffirms its 2026 revenue guidance, targeting $74 to $78 million, a 50% increase…
Powell Max Limited (PMAX) announced a share exchange agreement to acquire a minority stake in Blackrod Holdings, LLC, the parent company of Remington Firearms, with an exclusive 12-month option to acquire majority ownership. This move aligns with PMAX's strategy to expand into new markets and leverage the iconic Remington brand for growth. Both com…
Orrstown Bank has launched a newly redesigned website, Orrstown.com, featuring enhanced navigation, improved search, better mobile experience, and expanded financial education resources. The upgrade reflects the bank's commitment to responding to client feedback and improving accessibility while maintaining existing online banking platforms unchang…
BRP reported a Q2 net loss and suspended FY27 guidance after new U.S. tariffs drove a material near-term cost shock. The stock is down from its 52-week high and trading near $57. I argue a measured long here—entry $56.00, stop $50.00, target $72.00—offers attractive asymmetric upside over a mid-term window (45 trading days) if management executes o…
CenterPoint Energy is trading at multi-month lows as sector sentiment and rate‑sensitivity have driven the stock below key moving averages. Fundamentals remain intact — $24.3B market cap, stable regulated businesses, and a 2.45% yield — while technicals (RSI ~26.7) point to oversold conditions. This is a tactical mid‑term long trade: enter at $36.8…
Daré Bioscience announced the issuance of a new US patent strengthening the intellectual property for DARE-HPV, a proprietary fixed-dose formulation of lopinavir and ritonavir designed as a non-surgical, topical treatment for persistent high-risk HPV infection, currently in Phase 2 clinical trials with topline results expected in 2027. The program …
